טוען...
Efficacy of tolvaptan in a patient with right-sided heart failure and renal dysfunction refractory to diuretic therapy
The use of loop diuretics has been shown to deteriorate renal dysfunction and is associated with a poor prognosis in patients with heart failure (HF). Tolvaptan, a vasopressin V2-receptor antagonist, has been reported to be effective in treating HF due to its potent effects of water diuresis and is...
שמור ב:
| הוצא לאור ב: | J Cardiol Cases |
|---|---|
| Main Authors: | , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Japanese College of Cardiology
2014
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6278578/ https://ncbi.nlm.nih.gov/pubmed/30534332 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jccase.2014.02.003 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|